2 CASES FROM THE SPECTRUM OF NONALCOHOLIC STEATOHEPATITIS

被引:89
作者
ABDELMALEK, M
LUDWIG, J
LINDOR, KD
机构
[1] MAYO CLIN & MAYO FDN,DIV GASTROENTEROL & INTERNAL MED,ROCHESTER,MN 55905
[2] MAYO CLIN & MAYO FDN,DIV ANAT PATHOL,ROCHESTER,MN 55905
关键词
CIRRHOSIS; NONALCOHOLIC STEATOHEPATITIS;
D O I
10.1097/00004836-199503000-00011
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Nonalcoholic steatohepatitis is a poorly understood disease that mimics alcoholic liver disease histologically. Its natural history is not well defined, although gradual progression to cirrhosis has been described. Most patients with this condition have been obese, with or without associated diabetes or hyperlipidemia. No known effective treatment exists for nonalcoholic steatohepatitis, although weight loss may have a beneficial effect. We report two cases of nonalcoholic steatohepatitis. One patient with well-established nonalcoholic steatohepatitis had cirrhosis with a complete loss of fat on subsequent liver biopsy despite a gain in weight, simulating cryptogenic cirrhosis. In another patient, the condition improved after use of ursodeoxycholic acid; this agent may be a potential therapeutic agent for the treatment of nonalcoholic steatohepatitis. We believe these two cases represent the spectrum of this condition: on the one end is a progressive liver disease that in some instances may be a cause of cryptogenic cirrhosis; at the other end, a potentially treatable liver condition.
引用
收藏
页码:127 / 130
页数:4
相关论文
共 20 条
[1]   IMMUNOSUPPRESSIVE PROPERTIES OF CHENODEOXYCHOLIC AND URSODEOXYCHOLIC ACIDS IN THE MOUSE [J].
CALMUS, Y ;
WEILL, B ;
OZIER, Y ;
CHEREAU, C ;
HOUSSIN, D ;
POUPON, R .
GASTROENTEROLOGY, 1992, 103 (02) :617-621
[2]   FASTING IN OBESITY - ANOTHER CAUSE OF LIVER-INJURY WITH ALCOHOLIC HYALINE [J].
CAPRON, JP ;
DELAMARRE, J ;
DUPAS, JL ;
BRAILLON, A ;
DEGOTT, C ;
QUENUM, C .
DIGESTIVE DISEASES AND SCIENCES, 1982, 27 (03) :265-268
[3]   URSODEOXYCHOLIC ACID FOR PRIMARY SCLEROSING CHOLANGITIS [J].
CHAZOUILLERES, O ;
POUPON, R ;
CAPRON, JP ;
METMAN, EH ;
DHUMEAUX, D ;
AMOURETTI, M ;
COUZIGOU, P ;
LABAYLE, D ;
TRINCHET, JC .
JOURNAL OF HEPATOLOGY, 1990, 11 (01) :120-123
[4]  
CLAIN DJ, 1987, GASTROENTEROL CLIN N, V16, P239
[5]  
DEIHL AM, 1988, GASTROENTEROLOGY, V95, P1056
[6]  
ITOH S, 1979, ACTA HEPATO-GASTRO, V26, P90
[7]   STEATOSIS AND CIRRHOSIS IN AN OBESE DIABETIC - RESOLUTION OF FATTY LIVER BY FASTING [J].
KEEFFE, EB ;
ADESMAN, PW ;
STENZEL, P ;
PALMER, RM .
DIGESTIVE DISEASES AND SCIENCES, 1987, 32 (04) :441-445
[8]   THE IMMUNOSUPPRESSIVE EFFECT OF URSODEOXYCHOLIC ACID - A COMPARATIVE IN-VITRO STUDY ON HUMAN PERIPHERAL-BLOOD MONONUCLEAR-CELLS [J].
LACAILLE, F ;
PARADIS, K .
HEPATOLOGY, 1993, 18 (01) :165-172
[9]  
LEE RG, 1989, HUM PATHOL, V6, P594
[10]   GALLSTONE DISSOLUTION WITH URSODEOXYCHOLIC ACID IN PATIENTS WITH CHRONIC ACTIVE HEPATITIS AND 2 YEARS FOLLOW-UP - A PILOT-STUDY [J].
LEUSCHNER, U ;
LEUSCHNER, M ;
SIERATZKI, J ;
KURTZ, W ;
HUBNER, K .
DIGESTIVE DISEASES AND SCIENCES, 1985, 30 (07) :642-649